SCHEMBL4897574

SCHEMBL4897574

Cc1ccc(S(=O)(=O)NCCc2coc(-c3ccc(C(C)(C)C)cc3)n2)cc1C(=O)O

nearest known ligand 0.47

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
LMNA P02545 4/20 0.47
SMN1; SMN2 Q16637 3/20 0.41
HTT P42858 3/20 0.41
ALDH1A1 P00352 3/20 0.41
POLB P06746 3/20 0.37
PTPN5 P54829 1/20 0.37
KDM4E B2RXH2 4/20 0.37
MAPT P10636 3/20 0.37
MEN1 O00255 1/20 0.37
HPGD P15428 1/20 0.37
KMT2A Q03164 1/20 0.37
L3MBTL1 Q9Y468 1/20 0.37
MAPK1 P28482 2/20 0.37
PKM P14618 1/20 0.37
TP53 P04637 2/20 0.36
PPARG P37231 1/20 0.36
PPARA Q07869 1/20 0.36
RAB9A P51151 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4900708 0.93 PPARG (0.41) LMNASMN1; SMN2HTTALDH1A1POLB
SCHEMBL4906505 0.92 LMNA (0.46) LMNASMN1; SMN2HTTALDH1A1POLB
SCHEMBL4899812 0.90 PPARG (0.43) LMNASMN1; SMN2HTTALDH1A1POLB
SCHEMBL4907405 0.90 ALDH1A1 (0.39) LMNASMN1; SMN2HTTALDH1A1POLB
SCHEMBL4895920 0.88 LMNA (0.41) LMNASMN1; SMN2HTTALDH1A1POLB
SCHEMBL4906842 0.85 LMNA (0.45) LMNASMN1; SMN2HTTALDH1A1POLB
SCHEMBL4895720 0.84 PPARG (0.40) LMNASMN1; SMN2HTTALDH1A1POLB
SCHEMBL4906000 0.84 PPARG (0.41) LMNASMN1; SMN2HTTALDH1A1POLB
SCHEMBL4904501 0.83 PPARA (0.47) LMNASMN1; SMN2HTTALDH1A1POLB
SCHEMBL4895911 0.83 LMNA (0.55) LMNASMN1; SMN2HTTALDH1A1POLB

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20080090829-A1 SUBSTITUTED HETEROARYL- AND PHENYLSULFAMOYL COMPOUNDS PFIZER INC. 2008-04-17 US disclosed
US-20080090829-A1 SUBSTITUTED HETEROARYL- AND PHENYLSULFAMOYL COMPOUNDS PFIZER INC. 2008-04-17 US disclosed
US-20080090829-A1 SUBSTITUTED HETEROARYL- AND PHENYLSULFAMOYL COMPOUNDS PFIZER INC. 2008-04-17 US disclosed
US-20060229363-A1 Substituted Heteroaryl- and Phenylsulfamoyl Compounds HAMANAKA ERNEST S 2006-10-12 US disclosed
US-20050288340-A1 Substituted heteroaryl- and phenylsulfamoyl compounds PFIZER INC 2005-12-29 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20060229363-A1 Substituted Heteroaryl- and Phenylsulfamoyl Compounds PPARA, PPARG, PPARD LMNA 317/4885SMN1; SMN2 3271/4885HTT 711/4885
US-20050288340-A1 Substituted heteroaryl- and phenylsulfamoyl compounds PPARA, PPARG, PPARD LMNA 319/4885SMN1; SMN2 3404/4885HTT 696/4885
US-20080090829-A1 SUBSTITUTED HETEROARYL- AND PHENYLSULFAMOYL COMPOUNDS PPARA, PPARG, PPARD LMNA 319/4885SMN1; SMN2 3404/4885HTT 696/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.